If you have Empire Blue Cross Blue Shield health insurance, visit StayWithNYP.com to learn about how your in-network access to Weill Cornell Medicine physicians may be impacted.
Cardiothoracic Surgery

The Department of Cardiothoracic Surgery is a recognized leader in heart, lung and esophagus surgery. Our experience with complex cardiothoracic issues and knowledge of the latest advances have helped to establish NewYork-Presbyterian|Weill Cornell Medicine as a major referral center for cardiovascular and thoracic patients from around the world.

Cardiac Surgery

The Division of Cardiac Surgery provides expert care to patients who need:

  • Coronary artery bypass surgery
  • Valve repair/replacement
  • Surgery for adult congenital heart disease
  • Minimally Invasive Heart Surgery
  • Ventricular Assist Devices (VADs)
Learn More
Cardiac Surgery team

Thoracic Surgery

The Division of Thoracic Surgery offers the most advanced surgical care for:

  • Lung and esophageal cancers
  • Emphysema
  • Hyperhidrosis
  • Hiatal hernia
  • Pericardial & Pleural Effusions
  • Thoracentesis
Learn More
Thoracic Surgery team

Why Choose Weill Cornell?

New Advances

Multidisciplinary Airway Conference - Introduction to WCM's New Endobronchial Lung Volume Reduction Program

The Cardiothoracic Surgery Department is pleased to announce a multidisciplinary Airway Conference that emphasizes evidence-based approaches to the treatment of patients with complex airway conditions.  The event is open to interventional pulmonologists, pulmonologists, thoracic surgeons, gastroenterologists, ENTs, allergists, internists as well as nurses, residents, and fellows in each of the aforementioned specialties.  The format of the conference is case-based presentations followed by dynamic discussion moderated by Dr. Eugene Shostak. We will also make the first official announcement of Weill Cornell Medicine’s new endobronchial lung volume reduction program.  If you are unable to join in person, please consider joining us remotely.

For more details: Multidisciplinary Airway Conference - Introduction to WCM's New Endobronchial Lung Volume Reduction Program

A Sea of Presentations, and Those That Are Making Waves

By Brendon Stiles

October 8, 2018

I arrived in Toronto for the World Conference on Lung Cancer (WCLC) prepared for a whirlwind of activity. With committee and personal meetings to attend, as well as a handful of presentations to give, I barely had time to stop and reflect upon the remarkable collection of people that were gathered there. WCLC is relatively unique in that it brings together individuals treating and interested in lung cancer from numerous specialties: oncologists, surgeons, radiation oncologists, pathologists, epidemiologists, scientists, and others. The International Association for the Study of Lung Cancer (IASLC) who organizes WCLC has also wisely added patients and advocates to that mix, enabling a palpable focus on meaningful outcomes and on lung cancer advocacy. All of these stakeholders come together to cover the entire spectrum of lung cancer. However, within this vast ocean of presentations, it can feel a bit like paddling a rowboat to get from place to place to try to grasp the big picture of what is happening in the field.

To learn more about the article: A Sea of Presentations, and Those That Are Making Waves

Leading by Example

Cardiothoracicc surgeon Erin Mills Iannacone, MD, aims not only to bring more women to her field, but to broaden NYP/Weill Cornell's surgical offerings

Click here to learn more about the article

Symposium: Advances in Thoracic Oncology

The course is a one day, in depth meeting focused on updating healthcare providers on advances in thoracic oncology. Participants will be able to identify the advances in the management of patients with lung cancer.

Clinical Trials

The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.

Current Clinical Trials

 

US News National 2017-18

The Weill Cornell Medicine's Department of Cardiothoracic Surgery is proud to partner with NewYork-Presbyterian, ranked #3 in Adult Cardiology & Heart Surgery Hospital in the nation and #1 in NYC by U.S. News and World Report.